Andrea Baldini։ Aspirin Prophylaxis Is Effective But Still Off-Label In Some Countries
Andrea Baldini, Instute Director at IFCA Clinic, shared The Bone and Joint Journal’s post on LinkedIn, adding:
”More and more high level evidence for an established prophylaxis which in my country is still considered ‘off label’…”
The Bone and Joint Journal, shared a post on LinkedIn about a recent article by Billy I. Kim, adding:
”The risk of thromboembolic events must be weighed against the increased potential for bleeding with more potent anticoagulants.”
Title: Aspirin prophylaxis is safe and effective for venous thromboembolism prophylaxis in low-risk patients undergoing aseptic revision total knee arthroplasty
Authors: Billy I. Kim, Brian P. Chalmers, Fred D. Cushner, Peter K. Sculco
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award
-
Sep 24, 2026, 18:42Titilope Fasipe: Proud to Support American Society of Hematology’s SCD Initiative
-
Sep 24, 2026, 18:34Ifeanyichukwu Ifechidere: Why Coagulation Samples Can Be “Too Valuable to Throw Away”?
-
Sep 24, 2026, 18:33Aswin K. Mohan: When a Superpower Hears the Call for Blood
-
Sep 24, 2026, 18:31Mercy Lung’aho: Anemia Is Not Only An Iron Problem
-
Sep 24, 2026, 18:29Nick Hanson: Before a Dementia Diagnosis Check Vitamin B12
-
Sep 24, 2026, 18:28Rachel McBryan: Nearly One in Five Older Canadians Has Low Vitamin B12
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:26Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?